7. Treating Opioid and Polysubstance Use Disorders7. Treating Opioid and Polysubstance Use Disorders
Addiction Medicine Journal Club
Experts discuss treating opioid use disorder with polysubstance use, comparing buprenorphine and naltrexone, and hospital management guidelines.
33:19•26 Sept 2022
Tackling Opioid and Polysubstance Use: Insights from the Experts
“I think that sometimes, though, we use the term polysubstance, and I think often we look at it from like an opioid use disorder lens.”
How do you manage opioid use disorder when other substances are in the mix? Dr. John Keenan and Dr. Sonia Del Tredici dive into this challenging topic in this episode of the Addiction Medicine Journal Club. They break down a recent study from JAMA Network Open, comparing the effectiveness of buprenorphine and naltrexone in treating opioid use disorder alongside other substance use.
The hosts also review the Society of Hospital Medicine’s new consensus statement on managing opioid use disorder in hospital settings, offering practical takeaways for healthcare professionals. The episode doesn’t shy away from tough topics, including the risks of liver damage from depot buprenorphine. Drs. Keenan and Del Tredici also explore how the term 'polysubstance' is often used with an opioid-centric view, shedding light on the broader implications for treatment strategies.
This episode is packed with valuable information for anyone involved in addiction medicine, whether you're on the front lines or simply interested in the latest research.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.